Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-04-12 @ 5:03 PM
Study NCT ID:
NCT01946204
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-19
First Post:
2013-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Aragon Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Prostatic Neoplasms | View |